Showing results (1091-1100 of 2,737) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|April 1, 2015
Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patientsHye In Woo, Jung A Kim, Hyun Ae Jung, et al.
Pharmacogenomics|April 1, 2015
Role of dermatology in pharmacogenomics: drug-induced skin injuryRiccardo G Borroni
Pharmacogenomics|May 11, 2023
Association of OPRK1 rs963549 and rs997917 polymorphisms with opioid use disorder and related phenotypesSelin Özkan-Kotiloğlu, Dilek Kaya-Akyüzlü, Şafak Yalçın-Şahiner, et al.
Pharmacogenomics|June 24, 2014
No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sampleTim Moons, Marc De Hert, Gunther Kenis, et al.
Pharmacogenomics|June 24, 2014
Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic reviewSarah Cargnin, Claudio Jommi, Pier Luigi Canonico, et al.
Pharmacogenomics|June 24, 2014
Assessment of CYP450 genetic variability effect on methadone dose and toleranceHui-Ju Tsai, Sheng-Chang Wang, Sheng-Wen Liu, et al.
Pharmacogenomics|June 24, 2014
Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogeneticsAlmudena Sánchez Martín, Alicia Iglesias Gómez, Belén García-Berrocal, et al.
Pharmacogenomics|June 24, 2014
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancerGeraldine Perkins, Camilla Pilati, Helene Blons, et al.
Pharmacogenomics|January 22, 2014
Different phenotypes of the NAT2 gene influences hydralazine antihypertensive response in patients with resistant hypertensionLizania Borges Spinasse, Adalberto Rezende Santos, Philip Noel Suffys, et al.
Pharmacogenomics|January 22, 2014
Pharmacogenetics of nicotine addiction: role of dopamineAryeh I Herman, Elise E DeVito, Kevin P Jensen, et al.
Pageof 274